Robot‐Assisted Versus Laparoscopic Surgery for Rectal Cancer: A Propensity Score‐Matched Single‐Institution Study
Asian Journal of Endoscopic Surgery · 2026-01 · 19 (1)
DOI: 10.1111/ases.70375 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Asian Journal of Endoscopic Surgery, online erschienen am 03.09.2026. Verfasst von Hiroaki Shuto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan. Hauptthemen laut MEDLINE: Rectal Neoplasms, Laparoscopy, Adenocarcinoma, Robotic Surgical Procedures. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Robot‐assisted surgery (RS) is increasingly used for rectal cancer, but its clinical benefits over laparoscopic surgery (LS) remain uncertain. We compared perioperative and oncological outcomes between RS and LS after propensity score matching (PSM).
Methods
This single‐center retrospective study included 553 consecutive patients with clinical Stage I–III rectal adenocarcinoma who underwent RS or LS. PSM was performed using age, sex, body mass index, tumor location, neoadjuvant therapy, clinical T stage, clinical N stage, anastomosis status, and lateral pelvic lymph node dissection as covariates. The primary endpoint was 3‐year relapse‐free survival (RFS), and perioperative outcomes were secondary endpoints.
Results
PSM yielded 214 matched pairs. Operative time was significantly longer in the RS group than in the LS group (254 vs. 231 min; p < 0.001), whereas intraoperative blood loss was significantly lower (10 vs. 20 mL; p < 0.001). Conversion to open surgery was less frequent in the RS group (0.5% vs. 3.7%; p = 0.04). Three‐year RFS rates were comparable between the RS and LS groups (82.2% vs. 81.1%; p = 0.68), although the crude overall recurrence proportion was significantly lower in the RS group than in the LS group (15.0% vs. 22.9%; p = 0.048).
Conclusions
RS and LS achieved comparable mid‐term oncological outcomes in patients with Stage I–III rectal adenocarcinoma. RS was associated with a lower conversion rate and reduced intraoperative blood loss, suggesting selective perioperative advantages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
ORCID-Profile: Takashi Okuyama, Hidehiro Tajima, Hideyuki Yoshitomi
Zitieren
APA
Shuto, H., Okuyama, T., Miyazaki, S., Hosoya, H., Koshizuka, S., Naito, N., Hirotaka, G., Saito, K., Takeshita, E., Tajima, H., Nakamura, T., & Yoshitomi, H. (2026). Robot‐Assisted Versus Laparoscopic Surgery for Rectal Cancer: A Propensity Score‐Matched Single‐Institution Study. Asian Journal of Endoscopic Surgery, 19(1). https://doi.org/10.1111/ases.70375
Vancouver
Shuto H, Okuyama T, Miyazaki S, Hosoya H, Koshizuka S, Naito N, et al. Robot‐Assisted Versus Laparoscopic Surgery for Rectal Cancer: A Propensity Score‐Matched Single‐Institution Study. Asian Journal of Endoscopic Surgery. 2026;19(1). doi:10.1111/ases.70375
BibTeX
@article{Shuto2026,
author = {Shuto, Hiroaki and Okuyama, Takashi and Miyazaki, Shunya and Hosoya, Haruo and Koshizuka, Shinichiro and Naito, Natsumi and Hirotaka, Gambo and Saito, Kazuyuki and Takeshita, Emiko and Tajima, Hidehiro and Nakamura, Takatoshi and Yoshitomi, Hideyuki},
title = {Robot‐Assisted Versus Laparoscopic Surgery for Rectal Cancer: A Propensity Score‐Matched Single‐Institution Study},
journal = {Asian Journal of Endoscopic Surgery},
year = {2026},
volume = {19},
number = {1},
doi = {10.1111/ases.70375}
}
EUVIMED